載入...
Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons
This review provides insight into the role of engineered T-cell receptors (TCRs) in immunotherapy. Novel approaches have been developed to boost anticancer immune system, including targeting new antigens, manufacturing new engineered or modified TCRs, and creating a safety switch for endo-suicide ge...
Na minha lista:
| 發表在: | Front Immunol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8042275/ https://ncbi.nlm.nih.gov/pubmed/33859650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.658753 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|